Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial.
作者信息
Ferreira Diana H, Ekström Magnus, Bajwah Sabrina, Fazekas Belinda, Currow David C
机构信息
Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia
Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden.
出版信息
Eur Respir J. 2023 Sep 28;62(3). doi: 10.1183/13993003.00702-2023. Print 2023 Sep.
PMID:37678949
Abstract
摘要
相似文献
1
Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial.
Eur Respir J. 2023 Sep 28;62(3). doi: 10.1183/13993003.00702-2023. Print 2023 Sep.
2
Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.持续释放吗啡治疗慢性阻塞性肺疾病难治性呼吸困难对健康状况的影响：一项随机临床试验。
JAMA Intern Med. 2020 Oct 1;180(10):1306-1314. doi: 10.1001/jamainternmed.2020.3134.
3
Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.定期、低剂量、延长释放吗啡对慢性阻塞性肺疾病慢性呼吸困难的影响：BEAMS 随机临床试验。
JAMA. 2022 Nov 22;328(20):2022-2032. doi: 10.1001/jama.2022.20206.
4
Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study.定期服用低剂量持续释放吗啡缓解持续呼吸困难的人群中的睾酮水平：一项探索性研究。
J Palliat Med. 2023 Mar;26(3):402-405. doi: 10.1089/jpm.2022.0381. Epub 2022 Nov 17.
5
Patients' and their caregivers' experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study.患者及其护理人员对慢性阻塞性肺疾病相关慢性呼吸困难使用常规、低剂量、持续释放吗啡的体验：一项定性研究。
BMJ Open Respir Res. 2022 May;9(1). doi: 10.1136/bmjresp-2022-001210.
6
Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.常规、持续释放吗啡治疗慢性呼吸困难：一项多中心、双盲、随机、安慰剂对照试验。
Thorax. 2020 Jan;75(1):50-56. doi: 10.1136/thoraxjnl-2019-213681. Epub 2019 Sep 26.
7
Patients' and caregivers' experiences of driving with chronic breathlessness before and after regular low-dose sustained-release morphine: A qualitative study.慢性呼吸急促患者及照料者在规律服用低剂量缓释吗啡前后的驾车体验：一项定性研究。
Palliat Med. 2020 Sep;34(8):1078-1087. doi: 10.1177/0269216320929549. Epub 2020 Jun 10.
8
The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden: An exploratory analysis of the BEAMS trial.常规低剂量缓释吗啡治疗慢性呼吸困难对照顾者负担的影响：BEAMS试验的探索性分析
Palliat Med. 2024 Jan;38(1):156-162. doi: 10.1177/02692163231211227. Epub 2023 Nov 17.
9
Change in persisting breathlessness during treatment with regular, low-dose, sustained-release morphine.
Intern Med J. 2022 Oct;52(10):1845-1846. doi: 10.1111/imj.15902.
10
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.一项关于常规低剂量缓释吗啡治疗慢性呼吸困难的实用性、III期、多中心、双盲、安慰剂对照、平行组、剂量递增随机试验：呼吸困难、运动与硫酸吗啡（BEAMS）研究方案。
BMJ Open. 2017 Jul 17;7(7):e018100. doi: 10.1136/bmjopen-2017-018100.
引用本文的文献
1
Patient-centered care in pulmonary fibrosis: access, anticipate, and act.肺纤维化中的以患者为中心的护理：获得、预见和行动。
Respir Res. 2024 Nov 1;25(1):395. doi: 10.1186/s12931-024-02997-7.
Zotero 插件